Therapeutic Horizons for Dry AMD

Related

• 

  Geographic Atrophy in the Canadian Treat and Extend Trial With Ranibizumab in nAMD Patients: CANTREAT Study 24-Month Results

  Peter J. Kertes, MD, FRCS(C)

  Annual Meeting Talks

  2019

• 

  Episode 157: March Retinal Physician Review with Dr. Shriji Patel including discussion of complement inhibition for AMD, faricimab, brolucizimab, and prefilled syringes for injectable medications

  Jayanth Sridhar, MD

  Member Podcasts

  2018

• 

  Surveying the Dry AMD Landscape. Is help on the way?

  David S. Boyer, MD

  Updates from the Field

  2019